Gut Metabolite ImP Confirmed as Cause of Atherosclerosis, Opening Path to Blood Tests and I1R-Blocking Treatments

The Nature paper reveals how ImP activates the imidazoline-1 receptor to drive arterial inflammation, paving the way for blood-based diagnostics followed by clinical trials of I1R blockers.